Medical Device Coatings Market (Hydrophilic Coatings, Anti-Microbial Coatings, Anti-Thrombogenic Coatings, Drug-Eluting Coatings and Other Coatings) for Orthopedics, Neurology, Cardiovascular, General Surgery, Gynecology, Dentistry and Other End-users: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Global medical device coatings market will grow USD 11.8 billion by end of 2021,at a CAGR of around 7.8% between 2016 and 2021

30-Aug-2016 | Number of pages: 110 | Report Code: ZMR-116 | Report Format : | Status : Published

Abstract

The report provides analysis and forecast for the medical device coatings market on a regional and global level. The study provides historic data of 2015 and forecast from 2016 to 2021 based on revenue (USD billion) and volume (kilo tons). The study provides drivers and restraints for the medical device coatings market coupled along with the effect they have on the demand over the forecast period. Moreover, the report also covers the analysis of opportunities existing in the medical device coatings market on a global level.

With the objective to give the users of this report a complete view on the medical device coatings market and to better understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the medical device coatings market has also been covered. The study shares a market attractiveness analysis, wherein product segments and end-user segments are explained based on their general attractiveness, market size, and growth rate.

The study provides a clear view on the medical device coatings market by segmenting the market on the basis of end-user segment, product segment and regions. All the segments have been analyzed on the basis of present and future trends and the market is estimated from 2015 to 2021. Based on product segment, the medical device coatings market has been segmented into hydrophilic coatings, anti-microbial coatings, anti-thrombogenic coatings, drug-eluting coatings, and others. Based on the end-user segment, the medical Device Coatings market has been segmented into orthopedics, neurology, cardiovascular, general surgery, gynecology, dentistry and others. The regional segmentation covers the current and forecast demand for Latin America, Europe, North America, Asia-Pacific, and the Middle East and Africa which is furthermore segmented into major countries including Germany, France, UK, China, Japan, India, U.S., and Brazil.

The report also includes comprehensive profiles of end players such as Hydromer, Inc., Hemoteq AG, Covalon Technologies Ltd., SurModics, Inc., Royal DSM N.V., BioCoat, Inc., Coatings2Go, LLC, Harland Medical Systems, Inc., Merit Medical Systems, Inc., Sono-Tek Corporation., PPG Industries, Inc. and Precision Coating Company, Inc. and others. The thorough description of players includes parameters such as financial overview, company overview, business, and recent developments of the company.

This report segments the global medical device coatings market as follows:

Global Medical Device Coatings Market: Product Segment Analysis

  • Hydrophilic Coatings
  • Anti-Microbial Coatings
  • Anti-Thrombogenic Coatings
  • Drug-Eluting Coatings
  • Other Coatings

Global Medical Device Coatings Market: End-user Segment Analysis

  • Orthopedics
  • Neurology
  • Cardiovascular
  • General Surgery
  • Gynecology
  • Dentistry
  • Others

Global Medical Device Coatings Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Contrast Media/Contrast Agent Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1359 | Report Format:

Global Contrast Media/Contrast Agent Market: Overview To enhance the contrast of the structures or fluids inside the body contrast medium or the contrast agent is used in the medical imaging. The anatomical organs and structures are imaged better as the image contrast is increased. Thus, it is v...Read More

Continuous Renal Replacement Therapy (CRRT) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1358 | Report Format:

Global Continuous Renal Replacement Therapy (CRRT) Market: Overview A process wherein extracorporeal blood purification is done to substitute for the renal dysfunction for an extended period of time is known as continuous renal replacement therapy (CRRT). It is a therapy of renal replacement for...Read More

Superdisintegrants Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1354 | Report Format:

Global Superdisintegrants Market: Overview Superdisintegrant is a kind of excipient that is used for the tablet-based drug delivery in the pharmaceutical industry. To help the solid dosage form drugs such as pills or tablets disintegrate when they are submerged in the liquid superdisintegrants a...Read More

Medication Management Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1349 | Report Format:

Global Medication Management Market: Overview To manage and support the medicine management cycle an advanced system is developed known as medication management. In the hospitals, the medication management system is used for prescribing, supplying and administering the medicines. The use of the ...Read More

Hepatitis C Drug Market for Hospitals, Private labs, Physician Offices, Public Health Labs and Blood Banks - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Mar-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-1326 | Report Format:

The report covers forecast and analysis for the Hepatitis C drug market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based on revenue (USD Billion). The study includes drivers and restraints for the Hepatitis C drug market along w...Read More

Choose License Type: